Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-058378
Filing Date
2020-05-08
Accepted
2020-05-08 07:01:18
Documents
2
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2019068d2_defa14.htm DEFA14A 21542
2 GRAPHIC tm2019068d2_defa14img001.jpg GRAPHIC 14942
  Complete submission text file 0001104659-20-058378.txt   43367
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 20858609
SIC: 2834 Pharmaceutical Preparations